+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 274693-26-4
274693-26-4,MFCD23160137
Catalog No.:AA00BF0D

274693-26-4 | 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$29.00   $21.00
- +
10g
95%
in stock  
$329.00   $231.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00BF0D
Chemical Name:
2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
CAS Number:
274693-26-4
Molecular Formula:
C26H32F2N6O4S
Molecular Weight:
562.6319
MDL Number:
MFCD23160137
SMILES:
CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@@H]2[C@H]1OC(O2)(C)C)OCCO
Properties
Computed Properties
 
Complexity:
852  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
6  
Heavy Atom Count:
39  
Hydrogen Bond Acceptor Count:
12  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
10  
XLogP3:
3.6  

Downstream Synthesis Route
2-({(3aR,4S,6R,6aS)-6-7-chloro-5-(propylthio)-3H-1,2,3triazolo4,5-dpyrimidine-3-yl-2,2-dimethyltetrahydro-3aH-cyclopentadiened1,3dioxolene-4-yl}oxy)ethanol 
  376608-71-8    274693-26-4 

[1]Patent:WO2016/30704,2016,A1.Locationinpatent:Page/Pagecolumn15

[2]Patent:WO2010/30224,2010,A1.Locationinpatent:Page/Pagecolumn10

[3]Patent:WO2014/102830,2014,A1.Locationinpatent:Page/Pagecolumn83-84

[4]Patent:CN103664958,2017,B.Locationinpatent:Paragraph0090-0092

[5]Patent:CN105153167,2017,B.Locationinpatent:Paragraph0055-0057;0064

[6]Patent:CN107337675,2017,A.Locationinpatent:Paragraph0032;0043;0062-0071;0095;0114-0123

[7]Patent:CN108329320,2018,A.Locationinpatent:Paragraph0124;0153-0168

[8]Patent:CN108276417,2018,A.Locationinpatent:Paragraph0153;0159;0160;0161;0162;0163;0164-0168

[9]Patent:CN108892670,2018,A.Locationinpatent:Page/Pagecolumn8-17

[1]Patent:CN106866682,2017,A.Locationinpatent:Paragraph0045;0046;0047;0048

[2]Patent:CN108299441,2018,A.Locationinpatent:Paragraph0056;0063;0065;0066;0073

[3]Patent:CN108276417,2018,A.Locationinpatent:Paragraph0169;0175;0176;0177;0178;0179;0180-0189

[4]Patent:CN108892670,2018,A.Locationinpatent:Page/Pagecolumn8-18

[5]BioorganicandMedicinalChemistryLetters,2012,vol.22,p.3598-3602

[6]Patent:EP2586773,2013,A1.Locationinpatent:Paragraph0135-0136

[7]Patent:WO2013/60837,2013,A1.Locationinpatent:Page/Pagecolumn42

[8]Patent:CN104059069,2016,B.Locationinpatent:Paragraph0065-0070

[9]Patent:CN105669681,2016,A.Locationinpatent:Paragraph0031

[10]Patent:CN107337675,2017,A.Locationinpatent:Paragraph0032;0043;0072-0087;0095;0124-0139

[11]Patent:WO2016/30704,2016,A1.Locationinpatent:Page/Pagecolumn15;16

[12]Patent:US2016/102101,2016,A1.Locationinpatent:Paragraph0052

[13]Patent:CN105153167,2017,B.Locationinpatent:Paragraph0058-0060

[14]Patent:WO2010/30224,2010,A1.Locationinpatent:Page/Pagecolumn11-12

[15]Patent:WO2011/17108,2011,A2.Locationinpatent:Page/Pagecolumn45-46

[16]Patent:WO2012/85665,2012,A2

[17]Patent:WO2012/138981,2012,A2.Locationinpatent:Page/Pagecolumn48-49

[18]Patent:WO2014/102830,2014,A1.Locationinpatent:Page/Pagecolumn84-86

[19]Patent:WO2014/118808,2014,A2.Locationinpatent:Page/Pagecolumn7

[20]Patent:WO2015/162630,2015,A1.Locationinpatent:Page/Pagecolumn39

[21]Patent:WO2016/1851,2016,A1.Locationinpatent:Page/Pagecolumn21-22

[22]Patent:WO2016/38520,2016,A1.Locationinpatent:Page/Pagecolumn34

[23]Patent:WO2016/128996,2016,A2.Locationinpatent:Page/Pagecolumn15

[24]Patent:CN103664958,2017,B.Locationinpatent:Paragraph0093-0095

[25]Patent:CN107089984,2017,A.Locationinpatent:Paragraph0041;0051;0060;0069

[26]Patent:CN104230818,2018,B.Locationinpatent:Paragraph0284-0286

[27]Patent:CN106543191,2017,A.Locationinpatent:Paragraph0051-0055;0062-0066;0073-0078

[28]Patent:CN103626743,2018,B.Locationinpatent:Paragraph0063-0066

[29]Patent:CN108329320,2018,A.Locationinpatent:Paragraph0169-0201

[30]Patent:CN110183436,2019,A.Locationinpatent:Paragraph0019-0025

[31]Patent:KR2019/105389,2019,A.Locationinpatent:Paragraph0036-0037

[1]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2011/17108,2011,A2

[2]Zhang,Hao;Liu,Jun;Zhang,Luyong;Kong,Lingyi;Yao,Hequan;Sun,Hongbin[BioorganicandMedicinalChemistryLetters,2012,vol.22,#11,p.3598-3602]

[3]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2012/85665,2012,A2

(1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine 
 
2-({(3aR,4S,6R,6aS)-6-7-chloro-5-(propylthio)-3H-1,2,3triazolo4,5-dpyrimidine-3-yl-2,2-dimethyltetrahydro-3aH-cyclopentadiened1,3dioxolene-4-yl}oxy)ethanol 
  274693-26-4 

[1]Patent:WO2011/17108,2011,A2.Locationinpatent:Page/Pagecolumn45

[2]Patent:CN105669681,2016,A.Locationinpatent:Paragraph0030

[3]BioorganicandMedicinalChemistryLetters,2012,vol.22,p.3598-3602

[4]Patent:WO2012/142983,2012,A1.Locationinpatent:Page/Pagecolumn5-7

[1]Patent:WO2011/17108,2011,A2

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 274693-26-4
1265911-55-4

1265911-55-4

 220347-05-7

220347-05-7

 274693-27-5

274693-27-5

 1644461-85-7

1644461-85-7

 1616703-93-5

1616703-93-5

 274693-25-3

274693-25-3
Building Blocks
More >
Tags:274693-26-4 Molecular Formula|274693-26-4 MDL|274693-26-4 SMILES|274693-26-4 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |Fluorinated_Building_Blocks